Search

UPDATE (June 15, 2022): Health Canada is warning consumers about additional unauthorized products seized from three herbal medicine stores in Calgary, Alberta, after testing found they contain drugs that are not listed on the product label, which may…

Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…

Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…

Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health…

Apotex Inc. is recalling certain lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above the acceptable level. Apo-Acyclovir is a…

UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…

EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…

Health Canada is reminding Canadians of the risk of serious harm if children accidentally consume edible cannabis. Health Canada is aware of several cases of children being hospitalized, particularly after consuming products that are illegal and…

UPDATED INFORMATION – May 6, 2022 Further to the communication below, issued on March 15, 2022, regarding the potential for the presence of particulate matter in vials of Sodium Acetate Injection, USP (DIN 02139529) from lot 6126554, Fresenius Kabi…

UPDATED INFORMATION - March 11, 2022 On March 10, 2022, for the second time, the Federal Court set aside Health Canada’s decision to authorize RUZURGI (amifampridine), and the second Notice of Compliance (NOC) that had been issued on June 24, 2021…

Intravenous bags of Baxter’s 0.9% Sodium Chloride Injection, USP 500 mL and Lactated Ringer’s Injection, USP 500 mL from certain lots have the potential to leak when administered under pressure infusion due to a weak seal formation. Affected lots are…

Pfizer Canada ULC is recalling all lots of Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths, due to the presence of a nitrosamine impurity (N-nitroso-propranolol) above the acceptable level…

NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a…

An increased incidence of intraocular inflammation (IOI), including retinal vasculitis (RV) and retinal vascular occlusion (RO), was observed in patients who received BEOVU 6 mg with every 4 weeks (q4 week) dosing beyond the first 3 doses compared to…

UPDATE: January 26, 2022 Certain lots of Elavil (amitriptyline) and APO-Amitriptyline recalled due to a nitrosamine impurity AA Pharma Inc. is recalling two lots of Elavil (amitriptyline) (lots PY1829 and PY1830) and Apotex Inc. is recalling one…